Roberto Sanchez Urra

@baradit Es una mirada muy sesgada… Olvidas a los que vivimos y sufrimos el otro lado…. Inexcusable en un escritor como tú

Mi gran shock fue cuando descubrí que los chilenos que idolatraban a Pinochet no lo hacían por ignorancia, sino que encontraban que asesinar a adversarios políticos, perseguir a hombres y mujeres, torturar hasta quebrar almas y arrojar cadáveres desde helicópteros… estuvo bien.

@MuskElon3312 56

@ESVSmembership @MelVegCen Great Job , Melina … congrats

🚨 The April edition of EJVES Vascular Forum – Volume 63 is live! 🚨 This month’s issue delivers a brilliant mix of clinical insight, surgical innovation, and scientific rigour: ✍️ 1 editorial 🩺 5 case reports ⚡ 1 short report 🔬 4 original research articles 💭 2 expert commentaries 📨 1 correspondence 🖼️ 1 striking clinical image 📖 Read the full April edition here: ejvesreports.com/inpress 💡 Publishing original research? Every paper gets a professional visual abstract – see them all here: ejvesreports.com/content/visual… 📝 Submissions are open! Be part of the next issue and share your work with the vascular community. @vascularis, @FLareyre, @MariaKatsarou14, Francisco Álvarez Marcos, @EJVES_ESVS #ejvesforum #VascularSurgery #AcademicPublishing #VascularResearch #CallForSubmissions #OpenAccess

Honoured by the opportunity that the PVI COURSE 2024 gives me to share with my colleagues the most challenging case I have had in my entire professional life …

@FLareyre @EJVES_ESVS @vascularis @bazinger_z @Jonnyboyle1 @VenerMa @VASCevidence @CarlotaFPrendes @jmills1955 @AWBeckMD Congrats!!!

Very happy to start a new position as Associate Editor of the EJVES VF @EJVES_ESVS !!! Eager to start 😁 @vascularis @bazinger_z @Jonnyboyle1 @VenerMa @VASCevidence @CarlotaFPrendes @jmills1955 @AWBeckMD

@EJVES_ESVS Bravo!!!!!👏👏👏

📚🔥 The 2022 Journal IFs are here! We're thrilled to announce that our journal has maintained its leadership position🎉! Excitingly, #EJVESforum has also achieved an IF for the first time! Stay tuned for more groundbreaking research in the future!

@FLareyre @SCVE_fr @hopitalAntibes @LareyreRaffort @CHUdeNice Congrats

Very pleased to present the work of our team at the annual vascular meeting @SCVE_fr-Lyon on AI-enhanced automatic detection of visceral arterial aneurysm @hopitalAntibes @LareyreRaffort @CHUdeNice

@EJVES_ESVS @FLareyre @MelVegCen Congratulations again.. I hope ear about your work in the near future..

Today 16:00-16:30 CET LIVE TWITTER #EJVESforum discussion with main author of "Robot Assisted Laparoscopy for Median Arcuate Ligament Syndrome Relief" L. Magnus, on technology and more! Just read and reply to this Tweet, follow the thread below... #openaccess @FLareyre @MelVegCen

@EJVES_ESVS @FLareyre @MelVegCen Without a doubt, more studies are required… What come in the future… a multicenter cooperative study perhaps? given the low frequency of MALS…

@EJVES_ESVS @FLareyre @MelVegCen There seems to be a consensus that the biggest drawback of adding robotic surgery would be the high cost. Do you have some estimate (%) of how much the procedure is more expensive compared to conventional laparoscopic surgery?

@LMagnus7 @EJVES_ESVS @FLareyre @MelVegCen In short, in your experience, what are the most relevant advantages that the robot brings to conventional laparoscopic surgery?

@EJVES_ESVS @FLareyre @MelVegCen In short, in your experience, what are the most relevant advantages that the robot brings to conventional laparoscopic surgery?

@LMagnus7 @EJVES_ESVS @FLareyre @MelVegCen Congrats for your interesting paper!!

@EJVES_ESVS @FLareyre @MelVegCen Hello there

@rhigashita @EJVES_ESVS @MelVegCen Many thanks, Dr. Higashita for join us in this interesting chat…

@EJVES_ESVS @MelVegCen We are ready.

TODAY 13:00-13:30 CET (corrected time!!!) LIVE TWITTER #EJVESforum discussion on biografts, with Dr. Higashita, researcher of a vascular graft “Biotube” in a goat model. ejvesreports.com/article/S2666-… Join us and participate by simply replying to this Tweet. #openaccess @MelVegCen

@EJVES_ESVS @MelVegCen Many thanks, Dr. Higashita for join us in this interesting chat…

@EJVES_ESVS @MelVegCen Apparently there are not many groups investigating in iBTA and biotubes despite its advantages… What do you think?

@rhigashita @EJVES_ESVS @MelVegCen Congratulations.. iBTA would allow the availability of TEVG off the shelf… Perhaps in the near future…in the management of chronic arterial disease, wouldt it be possible to think that patients with PAD were their own bioreactor?

@EJVES_ESVS @MelVegCen We are thrilled to share that we enrolled the first patient and successfully embedded the mold into the patient's subcutaneous pouches this week. Waiting for tissue formation for 2 month.

@EJVES_ESVS @MelVegCen There is no answer from Dr. Higashita...

@rhigashita @EJVES_ESVS @MelVegCen In your opinion, what are the main advantages of iBTA and Biotubes when compared to other TEVG techniques like scaffold based methods?